Navigation Links
PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
Date:11/20/2007

as a consultant on health outcomes to the U.K. Department of Health for more than 15 years. Dr. Kiri received an MSc degree in Operational Research from the University of Sussex and a Ph.D. from the University of Bradford, both located in the U.K. Dr. Kiri has been appointed as Adjunct Professor of Biostatistical Epidemiology at the University of Limerick in Ireland. His other academic appointments have included serving as a lecturer at the London School of Hygiene and Tropical Medicine and at the Department of Epidemiology at the University of Surrey, in the U.K. Dr. Kiri has been elected as a Chartered Statistician by the U.K. Royal Statistical Society.

Note: The International Society for Pharmacoepidemiology (ISPE) defines pharmacoepidemiology as the study of the utilization and effect of drugs in large numbers of people. ISPE defines epidemiology as the study of distribution and determinants of diseases in populations.

About PAREXEL International

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 64 locations throughout 51 countries around the world, and has approximately 7,000 employees. For more information about PAREXEL International visit

SOURCE PAREXEL International Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
7. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
(Date:7/2/2015)... -- Pharma Major Lupin Limited anunció ... ZAO "Biocom" en Rusia bajo ciertas condiciones de ... en el mercado farmacéutico de Rusia que registró ... uno de los 10 principales mercados farmacéuticos del ... una década, el mercado farmacéutico ruso registró un ...
(Date:7/2/2015)... ResMed Inc. (NYSE: RMD ) today announced ... ended June 30, 2015 results on Thursday, July 30, 2015, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... MEMPHIS, Tenn., Sept. 9 The National,Coalition ... the proposed cuts to,the HIV/AIDS Medi-Cal pilot ... medications for thousands of Californians living with,HIV/AIDS. ... of recent studies,demonstrating that these pharmacy services ...
... Sept. 9 Ardea Biosciences, Inc.,(Nasdaq: RDEA ) ... Company,s lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119,at the ... Palms Resort & Convention Center in Orlando., ... Date/Time: Tuesday, October 7, 2008 from 10:30 a.m. - ...
Cached Medicine Technology:NCPS Outraged at HIV/AIDS Medi-Cal Cuts 2Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting 2
(Date:7/4/2015)... ... 05, 2015 , ... Dating a real millionaire online can be more difficult. ... service and strives to remove the worries from meeting partners. Recently, the site ... of 2015 and readers have responded with excitement. , “There's quite a ...
(Date:7/4/2015)... California (PRWEB) , ... July 04, 2015 , ... ... earned the solar industry’s leading recognition of technical sales expertise from the North ... PV Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established ...
(Date:7/3/2015)... Greenville, SC (PRWEB) , ... ... ... Society has announced the sessions and speaker lineup for its 2015 ... nursing, taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief nursing ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... said First Choice Emergency Room , the largest network of independent freestanding emergency ... the new facility medical director of our Sienna Plantation facility,” said Executive Medical Director ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... wooden Al Gore, former US vice president and presently a ... the world Saturday next. ,He is behind the ... and rock music featuring various artists planned to take place ... the global warming crisis. , The concerts have ...
... (AMS), which affects about half of those ascending to heights ... pulmonary or cerebral edema. ,The interest of the general ... past 25 years. This change is partly due to media ... In spite of these apparent changes, it is unknown whether ...
... out of ten Americans suffer some form of alcohol abuse ... study of drinking and dependency. ,Some 12.5 ... to alcohol dependence during their lives, including 3.8 percent who ... 2001-2002 survey. ,In addition, researchers led by Deborah ...
... announced that a team led by Dr. Yang Xiaofeng ... to assess clinical efficacy, safety, and feasibility of ... peripheral vascular disease of the lower extremities. ... for ataxia, cerebral palsy, spinal cord injury and MS ...
... today that the U.S. Food and Drug Administration (FDA) has ... Tamiflu(R) (oseltamivir phosphate) capsules in 30 mg and 45 mg ... the treatment and prevention of influenza types A and B ... a longer shelf life than the liquid suspension formulation (five ...
... will inaugurate a two-day conference on rural drinking water ... ,The conference will focus on ensuring sustainability in drinking ... rural areas of the country by 2012. ... as, progress under Bharat Nirman, issues of sustainability and ...
Cached Medicine News:Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 2Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 3Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Adult Stem Cells Show Promise for Peripheral Vascular Disease 2Health News:Tamiflu 30 Mg and 45 Mg Capsules Approved by FDA 2
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
... ToRCH Plus Control is a ... monitor the performance of the ... and assays. A weak positive ... you to monitor the performance ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Medicine Products: